Amylyx Pharmaceuticals Inc (AMLX) — Cash Flow Quality Index

Latest as of December 2023: 2.86x

Amylyx Pharmaceuticals Inc (AMLX) has a Cash Flow Quality Index of 2.86x as of December 2023. Operating cash flow of $13.55 Million exceeds net income of $4.73 Million, indicating high earnings quality where cash backs reported profits. Explore Amylyx Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

2.86x
Operating CF / Net Income

Operating Cash Flow

$13.55 Million
USD

Net Income

$4.73 Million
USD

Data as of

Dec 2023
Most recent filing

Amylyx Pharmaceuticals Inc Cash Flow Quality Index (2023–2023)

Historical Cash Flow Quality Index for Amylyx Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Amylyx Pharmaceuticals Inc.

Annual Cash Flow Quality Index for Amylyx Pharmaceuticals Inc (2023–2023)

Year-by-year earnings quality comparison for Amylyx Pharmaceuticals Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2023 0.24x $11.92 Million $49.27 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.